{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:48:48Z","timestamp":1785523728819,"version":"3.56.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"DOI":"10.1007\/s11655-026-4238-1","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:09:35Z","timestamp":1785222575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chinese Medicine for Renal Fibrosis Prevention and Treatment in Chronic Kidney Disease: Pharmacological Mechanisms and Therapeutic Potential"],"prefix":"10.1007","author":[{"given":"Qiao-hua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-hua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-sheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-hua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"4238_CR1","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2024;105:S117\u2013S314.","journal-title":"Kidney Int"},{"key":"4238_CR2","unstructured":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020;395:709\u2013733."},{"key":"4238_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, et al. Chronic kidney disease. Lancet 2021;398:786\u2013802.","journal-title":"Lancet"},{"key":"4238_CR4","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories. Lancet 2018;392:2052\u20132090.","journal-title":"Lancet"},{"key":"4238_CR5","doi-asserted-by":"publisher","first-page":"101206","DOI":"10.1016\/j.mam.2023.101206","volume":"93","author":"BM Klinkhammer","year":"2023","unstructured":"Klinkhammer BM, Boor P. Kidney fibrosis: emerging diagnostic and therapeutic strategies. Mol Aspects Med 2023;93:101206.","journal-title":"Mol Aspects Med"},{"key":"4238_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","volume":"18","author":"L Li","year":"2022","unstructured":"Li L, Fu H, Liu Y. The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat Rev Nephrol 2022;18:545\u2013557.","journal-title":"Nat Rev Nephrol"},{"key":"4238_CR7","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1136\/gutjnl-2024-334634","volume":"74","author":"M Laiola","year":"2025","unstructured":"Laiola M, Koppe L, Larabi A, et al. Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study. Gut 2025;74:1624\u20131637.","journal-title":"Gut"},{"key":"4238_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.joim.2020.08.006","volume":"18","author":"QL Wang","year":"2020","unstructured":"Wang QL, Tao YY, Xie HD, et al. Fuzheng Huayu Recipe, a traditional Chinese compound herbal medicine, attenuates renal interstitial fibrosis via targeting the miR-21\/PTEN\/AKT axis. J Integr Med 2020;18:505\u2013513.","journal-title":"J Integr Med"},{"key":"4238_CR9","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1142\/S0192415X24500708","volume":"52","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang J, Xiang S, et al. Astragaloside I from Astragalus attenuates diabetic kidney disease by regulating HDAC3\/Klotho\/TGF- \u03b2 1 loop. Am J Chin Med 2024;52:1795\u20131817.","journal-title":"Am J Chin Med"},{"key":"4238_CR10","first-page":"2267","volume":"20","author":"Z Zuo","year":"2019","unstructured":"Zuo Z, Huang P, Jiang Y, et al. Acupuncture attenuates renal interstitial fibrosis via the TGF-\u03b2\/Smad pathway. Mol Med Rep 2019;20:2267\u20132275.","journal-title":"Mol Med Rep"},{"key":"4238_CR11","first-page":"125","volume":"30","author":"JY Sang","year":"2023","unstructured":"Sang JY, Zhang XQ, Zhou P, et al. The application effect of traditional Chinese medicine dietary nursing care in patients with nephrotic syndrome treated by methylprednisolone pulse therapy. Mod Nurse (Chin) 2023;30:125\u2013128.","journal-title":"Mod Nurse (Chin)"},{"key":"4238_CR12","first-page":"4210","volume":"42","author":"YL Zhang","year":"2022","unstructured":"Zhang YL, Liu YL, Lin ZC, et al. The influence of exercise management under the guidance of traditional Chinese medicine exercise theory on dialysis adequacy and micro-inflammatory state in MHD patients. Chin J Gerontol (Chin) 2022;42:4210\u20134214.","journal-title":"Chin J Gerontol (Chin)"},{"key":"4238_CR13","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA 2019;322:1294\u20131304.","journal-title":"JAMA"},{"key":"4238_CR14","doi-asserted-by":"publisher","first-page":"108240","DOI":"10.1016\/j.pharmthera.2022.108240","volume":"237","author":"Y Fu","year":"2022","unstructured":"Fu Y, Xiang Y, Li H, et al. Inflammation in kidney repair: mechanism and therapeutic potential. Pharmacol Ther 2022;237:108240.","journal-title":"Pharmacol Ther"},{"key":"4238_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","volume":"15","author":"PM Tang","year":"2019","unstructured":"Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol 2019;15:144\u2013158.","journal-title":"Nat Rev Nephrol"},{"key":"4238_CR16","doi-asserted-by":"publisher","first-page":"e130651","DOI":"10.1172\/jci.insight.130651","volume":"5","author":"F do Valle Duraes","year":"2020","unstructured":"do Valle Duraes F, Lafont A, Beibel M, et al. Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosis. JCI Insight 2020;5:e130651.","journal-title":"JCI Insight"},{"key":"4238_CR17","doi-asserted-by":"crossref","unstructured":"Ryu S, Shin JW, Kwon S, et al. Siglec-F-expressing neutrophils are essential for creating a profibrotic microenvironment in renal fibrosis. J Clin Invest 2022;132.","DOI":"10.1172\/JCI156876"},{"key":"4238_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduction Targeted Ther 2023;8:129.","journal-title":"Signal Transduction Targeted Ther"},{"key":"4238_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","volume":"589","author":"C Kuppe","year":"2021","unstructured":"Kuppe C, Ibrahim MM, Kranz J, et al. Decoding myofibroblast origins in human kidney fibrosis. Nature 2021;589:281\u2013286.","journal-title":"Nature"},{"key":"4238_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.matbio.2018.02.020","volume":"71","author":"M Walraven","year":"2018","unstructured":"Walraven M, Hinz B. Therapeutic approaches to control tissue repair and fibrosis: extracellular matrix as a game changer. Matrix Biol 2018;71:205\u2013224.","journal-title":"Matrix Biol"},{"key":"4238_CR21","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1042\/CS20201016","volume":"135","author":"S Rayego-Mateos","year":"2021","unstructured":"Rayego-Mateos S, Campillo S, Rodrigues-Diez RR, et al. Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis. Clin Sci (Lond) 2021;135:1999\u20132029.","journal-title":"Clin Sci (Lond)"},{"key":"4238_CR22","doi-asserted-by":"publisher","first-page":"107787","DOI":"10.1016\/j.pharmthera.2020.107787","volume":"222","author":"J Prat-Duran","year":"2021","unstructured":"Prat-Duran J, Pinilla E, N\u00f8rregaard R, et al. Transglutaminase 2 as a novel target in chronic kidney disease\u2014methods, mechanisms and pharmacological inhibition. Pharmacol Ther 2021;222:107787.","journal-title":"Pharmacol Ther"},{"key":"4238_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41419-020-03322-y","volume":"12","author":"R Qi","year":"2021","unstructured":"Qi R, Wang J, Jiang Y, et al. Snai1\u2013induced partial epithelial-mesenchymal transition orchestrates p53-p21-mediated G2\/M arrest in the progression of renal fibrosis via NF- \u03baB-mediated inflammation. Cell Death Dis 2021;12:44.","journal-title":"Cell Death Dis"},{"key":"4238_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.matbio.2018.02.006","volume":"68\u201369","author":"LS Gewin","year":"2018","unstructured":"Gewin LS. Renal fibrosis: primacy of the proximal tubule. Matrix Biol 2018;68\u201369, 248\u2013262.","journal-title":"Matrix Biol"},{"key":"4238_CR25","doi-asserted-by":"publisher","first-page":"2354444","DOI":"10.1080\/0886022X.2024.2354444","volume":"46","author":"L Liao","year":"2024","unstructured":"Liao L, Tao P, Xu Q, et al. Bushen Huoxue Formula protects against renal fibrosis and pyroptosis in chronic kidney disease by inhibiting ROS\/NLRP3-mediated inflammasome activation. Ren Fail 2024;46:2354444.","journal-title":"Ren Fail"},{"key":"4238_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13020-021-00531-1","volume":"16","author":"W Wu","year":"2021","unstructured":"Wu W, Wang Y, Li H, et al. Buyang Huanwu Decoction protects against STZ-induced diabetic nephropathy by inhibiting TGF- \u03b2 \/Smad3 signaling-mediated renal fibrosis and inflammation. Chin Med 2021;16:118.","journal-title":"Chin Med"},{"key":"4238_CR27","first-page":"1374","volume":"25","author":"F Hao","year":"2024","unstructured":"Hao F, Guo AX. Clinical efficacy of Huangkui Capsules as an adjuvant therapy for chronic kidney disease. J Shanxi Univ Chin Med (Chin) 2024;25:1374\u20131378.","journal-title":"J Shanxi Univ Chin Med (Chin)"},{"key":"4238_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.phymed.2018.12.021","volume":"57","author":"W Han","year":"2019","unstructured":"Han W, Ma Q, Liu Y, et al. Huangkui Capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4\/NF-\u03baB signaling. Phytomedicine 2019;57:203\u2013214.","journal-title":"Phytomedicine"},{"key":"4238_CR29","doi-asserted-by":"publisher","first-page":"108897","DOI":"10.1016\/j.cbi.2019.108897","volume":"315","author":"NM Elsherbiny","year":"2020","unstructured":"Elsherbiny NM, Said E, Atef H, et al. Renoprotective effect of calycosin in high fat diet-fed\/STZ injected rats: effect on IL-33\/ST2 signaling, oxidative stress and fibrosis suppression. Chem Biol Interact 2020;315:108897.","journal-title":"Chem Biol Interact"},{"key":"4238_CR30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/ijms20051103","volume":"20","author":"R Li","year":"2019","unstructured":"Li R, Guo Y, Zhang Y, et al. Salidroside ameliorates renal interstitial fibrosis by inhibiting the TLR4\/NF-\u03baB and MAPK signaling pathways. Int J Mol Sci 2019;20:1103.","journal-title":"Int J Mol Sci"},{"key":"4238_CR31","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.2147\/IJGM.S490049","volume":"17","author":"J Shan","year":"2024","unstructured":"Shan J, Cao Z, Yu S. Advances in understanding diabetic kidney disease progression and the mechanisms of acupuncture intervention. Int J Gen Med 2024;17:5593\u20135609.","journal-title":"Int J Gen Med"},{"key":"4238_CR32","first-page":"587","volume":"22","author":"XB Sun","year":"2021","unstructured":"Sun XB, Wang S, Sun H, et al. Zusanli, Spleen and Kidney Shu acupoint embedding regulation of immune disorder improves microinflammation in CKD 2\u20133 stage patients. Chin J Integr Tradit West Nephrol (Chin) 2021;22:587\u2013590.","journal-title":"Chin J Integr Tradit West Nephrol (Chin)"},{"key":"4238_CR33","doi-asserted-by":"publisher","first-page":"116822","DOI":"10.1016\/j.bcp.2025.116822","volume":"234","author":"P Li","year":"2025","unstructured":"Li P, Dong X, Xu L, et al. TRIM21 knockout alleviates renal fibrosis by promoting autophagic degradation of mature TGF- \u03b2 1. Biochem Pharmacol 2025;234:116822.","journal-title":"Biochem Pharmacol"},{"key":"4238_CR34","doi-asserted-by":"publisher","first-page":"114031","DOI":"10.1016\/j.intimp.2025.114031","volume":"148","author":"X Xu","year":"2025","unstructured":"Xu X, Miao M, Zhu W, et al. Interferon regulatory factor 5 attenuates kidney fibrosis through transcriptional suppression of TGFBR1. Int Immunopharmacol 2025;148:114031.","journal-title":"Int Immunopharmacol"},{"key":"4238_CR35","doi-asserted-by":"publisher","first-page":"124637","DOI":"10.1016\/j.ijbiomac.2023.124637","volume":"241","author":"XY Li","year":"2023","unstructured":"Li XY, Chen HR, Kuang DD, et al. Laminaria japonica polysaccharide attenuates podocyte epithelial-mesenchymal transformation via TGF-\u03b2 1-mediated Smad3 and p38MAPK pathways. Int J Biol Macromol 2023;241:124637.","journal-title":"Int J Biol Macromol"},{"key":"4238_CR36","doi-asserted-by":"publisher","first-page":"14627","DOI":"10.1038\/s41598-018-32115-9","volume":"8","author":"S Li","year":"2018","unstructured":"Li S, Xiao X, Han L, et al. Renoprotective effect of Zhenwu Decoction against renal fibrosis by regulation of oxidative damage and energy metabolism disorder. Sci Rep 2018;8:14627.","journal-title":"Sci Rep"},{"key":"4238_CR37","doi-asserted-by":"publisher","first-page":"110746","DOI":"10.1016\/j.biopha.2020.110746","volume":"131","author":"W Liu","year":"2020","unstructured":"Liu W, Li Y, Xiong X, et al. Traditional Chinese medicine protects against hypertensive kidney injury in Dahl salt-sensitive rats by targeting transforming growth factor- \u03b2 signaling pathway. Biomed Pharmacother 2020;131:110746.","journal-title":"Biomed Pharmacother"},{"key":"4238_CR38","doi-asserted-by":"publisher","first-page":"969107","DOI":"10.3389\/fphar.2022.969107","volume":"13","author":"L Chen","year":"2022","unstructured":"Chen L, Ye Z, Wang D, et al. Chuan Huang Fang combining reduced glutathione in treating acute kidney injury (grades 1\u20132) on chronic kidney disease (stages 2\u20134): a multicenter randomized controlled clinical trial. Front Pharmacol 2022;13:969107.","journal-title":"Front Pharmacol"},{"key":"4238_CR39","doi-asserted-by":"publisher","first-page":"111348","DOI":"10.1016\/j.cellsig.2024.111348","volume":"122","author":"Y Fan","year":"2024","unstructured":"Fan Y, Kang S, Shao T, et al. Activation of SIRT3 by tanshinone IIA ameliorates renal fibrosis by suppressing the TGF- \u03b2 \/TSP-1 pathway and attenuating oxidative stress. Cell Signal 2024;122:111348.","journal-title":"Cell Signal"},{"key":"4238_CR40","doi-asserted-by":"publisher","first-page":"115898","DOI":"10.1016\/j.jep.2022.115898","volume":"302","author":"JL Zhang","year":"2023","unstructured":"Zhang JL, Du C, Poon CC, et al. Structural characterization and protective effect against renal fibrosis of polysaccharide from Ligustrum lucidum Ait. J Ethnopharmacol 2023;302:115898.","journal-title":"J Ethnopharmacol"},{"key":"4238_CR41","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/13880209.2020.1844241","volume":"58","author":"WR Liu","year":"2020","unstructured":"Liu WR, Lu HT, Zhao TT, et al. Fu-Fang-Jin-Qian-Cao Herbal Granules protect against the calcium oxalate-induced renal EMT by inhibiting the TGF-\u03b2\/smad pathway. Pharm Biol 2020;58:1115\u20131122.","journal-title":"Pharm Biol"},{"key":"4238_CR42","doi-asserted-by":"publisher","first-page":"156142","DOI":"10.1016\/j.phymed.2024.156142","volume":"135","author":"J Xie","year":"2024","unstructured":"Xie J, Lin H, Jin F, et al. Jia Wei Qingxin Lotus Seed Drink ameliorates epithelial mesenchymal transition injury in diabetic kidney disease via inhibition of JMJD1C\/SP1\/ZEB1 signaling pathway. Phytomedicine 2024;135:156142.","journal-title":"Phytomedicine"},{"key":"4238_CR43","doi-asserted-by":"publisher","first-page":"110241","DOI":"10.1016\/j.biopha.2020.110241","volume":"128","author":"Y He","year":"2020","unstructured":"He Y, Lu R, Wu J, et al. Salvianolic acid B attenuates epithelial-mesenchymal transition in renal fibrosis rats through activating Sirt1-mediated autophagy. Biomed Pharmacother 2020;128:110241.","journal-title":"Biomed Pharmacother"},{"key":"4238_CR44","doi-asserted-by":"publisher","first-page":"118772","DOI":"10.1016\/j.carbpol.2021.118772","volume":"276","author":"C Huang","year":"2022","unstructured":"Huang C, Jing X, Wu Q, et al. Novel pectin-like polysaccharide from Panax notoginseng attenuates renal tubular cells fibrogenesis induced by TGF- \u03b2. Carbohydr Polym 2022;276:118772.","journal-title":"Carbohydr Polym"},{"key":"4238_CR45","doi-asserted-by":"publisher","first-page":"e14041","DOI":"10.1111\/jfbc.14041","volume":"46","author":"HC Lin","year":"2022","unstructured":"Lin HC, Paul CR, Kuo CH, et al. Glycyrrhiza uralensis root extract ameliorates high glucose-induced renal proximal tubular fibrosis by attenuating tubular epithelial-myofibroblast transdifferentiation by targeting TGF- \u03b2 1\/Smad\/Stat3 pathway. J Food Biochem 2022;46:e14041.","journal-title":"J Food Biochem"},{"key":"4238_CR46","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1002\/tox.23553","volume":"37","author":"CY Lin","year":"2022","unstructured":"Lin CY, Lin YC, Paul CR, et al. Isoliquiritigenin ameliorates advanced glycation end-products toxicity on renal proximal tubular epithelial cells. Environ Toxicol 2022;37:2096\u20132102.","journal-title":"Environ Toxicol"},{"key":"4238_CR47","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1111\/bph.14842","volume":"176","author":"X Zhang","year":"2019","unstructured":"Zhang X, Lu H, Xie S, et al. Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation-related signalling pathways. Br J Pharmacol 2019;176:4745\u20134759.","journal-title":"Br J Pharmacol"},{"key":"4238_CR48","doi-asserted-by":"publisher","first-page":"134491","DOI":"10.1016\/j.ijbiomac.2024.134491","volume":"278","author":"T Liu","year":"2024","unstructured":"Liu T, Zhang Y, Wu Z, et al. Novel glucomannan-like polysaccharide from Lycium barbarum L. ameliorates renal fibrosis via blocking macrophage-to-myofibroblasts transition. Int J Biol Macromol 2024;278:134491.","journal-title":"Int J Biol Macromol"},{"key":"4238_CR49","doi-asserted-by":"publisher","first-page":"156324","DOI":"10.1016\/j.phymed.2024.156324","volume":"136","author":"T Xiang","year":"2024","unstructured":"Xiang T, Wang X, Huang S, et al. Inhibition of PKM2 by shikonin impedes TGF- \u03b2 1 expression by repressing histone lactylation to alleviate renal fibrosis. Phytomedicine 2024;136:156324.","journal-title":"Phytomedicine"},{"key":"4238_CR50","first-page":"172","volume":"48","author":"L Luo","year":"2023","unstructured":"Luo L, Ning SS, Yang SZ, et al. Effect of electroacupuncture on transforming growth factor- \u03b2 1 and renal tubular epithelial mesenchymal transformation in renal tissue of spontaneously hypertensive rats. Acupunct Res (Chin) 2023;48:172\u2013179.","journal-title":"Acupunct Res (Chin)"},{"key":"4238_CR51","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.2147\/DDDT.S457100","volume":"18","author":"X Huang","year":"2024","unstructured":"Huang X, Peng Y, Lu L, et al. Huangqi-Danshen Decoction against renal fibrosis in UUO mice via TGF-\u03b2 1 induced downstream signaling pathway. Drug Des Devel Ther 2024;18:4119\u20134134.","journal-title":"Drug Des Devel Ther"},{"key":"4238_CR52","doi-asserted-by":"publisher","first-page":"10682","DOI":"10.1038\/s41598-020-67690-3","volume":"10","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Zhu Y, Zhen T, et al. Transcriptomic analysis of the mechanisms of alleviating renal interstitial fibrosis using the traditional Chinese medicine Kangxianling in a rat model. Sci Rep 2020;10:10682.","journal-title":"Sci Rep"},{"key":"4238_CR53","first-page":"938","volume":"31","author":"CX Pang","year":"2019","unstructured":"Pang CX. Effect of Qiangshen Jianpi Decoction combined with tripterygium glycosides on diabetic nephropathy of Spleen and Kidney deficiency and the influence on renal fibrosis. Clin J Tradit Chin Med (Chin) 2019;31:938\u2013940.","journal-title":"Clin J Tradit Chin Med (Chin)"},{"key":"4238_CR54","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/13880209.2025.2498166","volume":"63","author":"X Yang","year":"2025","unstructured":"Yang X, Luo Q, Wu Z, et al. Tanshinone IIA reduces tubulointerstitial fibrosis by suppressing GSDMD-mediated pyroptosis. Pharm Biol 2025;63:364\u2013373.","journal-title":"Pharm Biol"},{"key":"4238_CR55","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.2147\/DDDT.S414179","volume":"17","author":"M Yao","year":"2023","unstructured":"Yao M, Lian D, Wu M, et al. Isoliensinine attenuates renal fibrosis and inhibits TGF-\u03b2 1\/Smad2\/3 signaling pathway in spontaneously hypertensive rats. Drug Des Devel Ther 2023;17:2749\u20132762.","journal-title":"Drug Des Devel Ther"},{"key":"4238_CR56","doi-asserted-by":"publisher","first-page":"121565","DOI":"10.1016\/j.lfs.2023.121565","volume":"320","author":"N Aobulikasimu","year":"2023","unstructured":"Aobulikasimu N, Lv H, Guan P, et al. Levistolide A ameliorates fibrosis in chronic kidney disease via modulating multitarget actions in vitro and in vivo. Life Sci 2023;320:121565.","journal-title":"Life Sci"},{"key":"4238_CR57","doi-asserted-by":"publisher","first-page":"119579","DOI":"10.1016\/j.jep.2025.119579","volume":"345","author":"XM Shan","year":"2025","unstructured":"Shan XM, Lu C, Chen CW, et al. Tangshenning Formula alleviates tubular injury in diabetic kidney disease via the Sestrin2\/AMPK\/PGC-1 \u03b1 axis: restoration of mitochondrial function and inhibition of ferroptosis. J Ethnopharmacol 2025;345:119579.","journal-title":"J Ethnopharmacol"},{"key":"4238_CR58","doi-asserted-by":"publisher","first-page":"18338","DOI":"10.1038\/s41598-021-97137-2","volume":"11","author":"XH Wang","year":"2021","unstructured":"Wang XH, Lang R, Zeng Q, et al. Jianpi Qushi Heluo Formula alleviates renal damages in passive Hemann nephritis in rats by upregulating Parkin-mediated mitochondrial autophagy. Sci Rep 2021;11:18338.","journal-title":"Sci Rep"},{"key":"4238_CR59","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ptr.7353","volume":"36","author":"J Li","year":"2022","unstructured":"Li J, Yang J, Zhu B, et al. Tectorigenin protects against unilateral ureteral obstruction by inhibiting Smad3-mediated ferroptosis and fibrosis. Phytother Res 2022;36:475\u2013487.","journal-title":"Phytother Res"},{"key":"4238_CR60","doi-asserted-by":"publisher","first-page":"104049","DOI":"10.1016\/j.jff.2020.104049","volume":"72","author":"SX Ding","year":"2020","unstructured":"Ding SX, Zhang H, Sun ZH, et al. Ginsenoside Rg1 protects against aging-induced renal interstitial fibrosis due to inhibition of tubular epithelial cells endoplasmic reticulum stress in SAMP8 mice. J Funct Foods 2020;72:104049.","journal-title":"J Funct Foods"},{"key":"4238_CR61","doi-asserted-by":"publisher","first-page":"115899","DOI":"10.1016\/j.biopha.2023.115899","volume":"169","author":"H Yu","year":"2023","unstructured":"Yu H, Tang H, Wang M, et al. Effects of total flavones of Abelmoschus manihot (L.) on the treatment of diabetic nephropathy via the activation of solute carriers in renal tubular epithelial cells. Biomed Pharmacother 2023;169:115899.","journal-title":"Biomed Pharmacother"},{"key":"4238_CR62","first-page":"162","volume":"29","author":"YJ Yang","year":"2022","unstructured":"Yang YJ. Influence of traditional Chinese medicine fumigation combined with moxibustion on quality of life in patients with chronic renal insufficiency. China Modern Med (Chin) 2022;29:162\u2013165.","journal-title":"China Modern Med (Chin)"},{"key":"4238_CR63","first-page":"497","volume":"47","author":"WJ Wei","year":"2022","unstructured":"Wei WJ, Liao MH, Tan YH, et al. Effect of electroacupuncture on renal vascular microcirculation in diabetic mice based on in vivo two-photon microscopy imaging. Acupunct Res (Chin) 2022;47:497\u2013503.","journal-title":"Acupunct Res (Chin)"},{"key":"4238_CR64","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.semcdb.2022.09.012","volume":"154","author":"CT Chao","year":"2024","unstructured":"Chao CT, Kuo FC, Lin SH. Epigenetically regulated inflammation in vascular senescence and renal progression of chronic kidney disease. Semin Cell Dev Biol 2024;154:305\u2013315.","journal-title":"Semin Cell Dev Biol"},{"key":"4238_CR65","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","volume":"15","author":"M Kato","year":"2019","unstructured":"Kato M, Natarajan R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat Rev Nephrol 2019;15:327\u2013345.","journal-title":"Nat Rev Nephrol"},{"key":"4238_CR66","doi-asserted-by":"publisher","first-page":"7251","DOI":"10.2147\/IJN.S514516","volume":"20","author":"J Shen","year":"2025","unstructured":"Shen J, Bin W, Lin X, et al. Klotho protein: a multifaceted guardian of healthy aging and its therapeutic potential. Int J Nanomed 2025;20:7251\u20137270.","journal-title":"Int J Nanomed"},{"key":"4238_CR67","first-page":"538","volume":"41","author":"LH Shu","year":"2025","unstructured":"Shu LH, Li N, Sang YH, et al. Clinical efficacy of Suyin Jiedu Prescription in the treatment of stage 3\u20135 chronic kidney disease of Kidney deficiency and turbid toxin type and its effect on serum Klotho. J Nanjing Univ Tradit Chin Med (Chin) 2025;41:538\u2013543.","journal-title":"J Nanjing Univ Tradit Chin Med (Chin)"},{"key":"4238_CR68","doi-asserted-by":"publisher","first-page":"154390","DOI":"10.1016\/j.phymed.2022.154390","volume":"106","author":"S Tao","year":"2022","unstructured":"Tao S, Yang L, Wu C, et al. Gambogenic acid alleviates kidney fibrosis via epigenetic inhibition of EZH2 to regulate Smad7-dependent mechanism. Phytomedicine 2022;106:154390.","journal-title":"Phytomedicine"},{"key":"4238_CR69","doi-asserted-by":"publisher","first-page":"2284211","DOI":"10.1080\/0886022X.2023.2284211","volume":"45","author":"Z Chen","year":"2023","unstructured":"Chen Z, Liang H, Yan X, et al. Astragalus polysaccharide promotes autophagy and alleviates diabetic nephropathy by targeting the lncRNA Gm41268\/PRLR pathway. Ren Fail 2023;45:2284211.","journal-title":"Ren Fail"},{"key":"4238_CR70","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.2147\/DDDT.S166525","volume":"12","author":"X Lei","year":"2018","unstructured":"Lei X, Zhang L, Li Z, et al. Astragaloside IV\/lncRNA-TUG1\/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats. Drug Des Devel Ther 2018;12:2785\u20132793.","journal-title":"Drug Des Devel Ther"},{"key":"4238_CR71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2018.05.037","volume":"206","author":"X Lei","year":"2018","unstructured":"Lei X, Zhang BD, Ren JG, et al. Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378\/TRAF5 signaling pathway. Life Sci 2018;206:77\u201383.","journal-title":"Life Sci"},{"key":"4238_CR72","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00018-024-05532-5","volume":"81","author":"XJ Li","year":"2024","unstructured":"Li XJ, Shan QY, Wu X, et al. Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis. Cell Mol Life Sci 2024;81:480.","journal-title":"Cell Mol Life Sci"},{"key":"4238_CR73","first-page":"160","volume":"48","author":"YQ Xu","year":"2023","unstructured":"Xu YQ, Huang YM, He MY, et al. Effect of Uremic Clearance Granules on improvement of chronic kidney disease in rats based on microbiome-metabolomics and its mechanism. China J Chin Mater Med (Chin) 2023;48:160\u2013169.","journal-title":"China J Chin Mater Med (Chin)"},{"key":"4238_CR74","doi-asserted-by":"publisher","first-page":"1180751","DOI":"10.3389\/fphar.2023.1180751","volume":"14","author":"C Song","year":"2023","unstructured":"Song C, Zhu Z, Liu L, et al. The efficacy and safety of Niaoduqing Granules in the treatment of diabetic kidney disease: a systematic review and meta-analysis. Front Pharmacol 2023;14:1180751.","journal-title":"Front Pharmacol"},{"key":"4238_CR75","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/13880209.2024.2345080","volume":"62","author":"X Dong","year":"2024","unstructured":"Dong X, Zhang J, Li W, et al. Yi-Shen-Hua-Shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study. Pharm Biol 2024;62:356\u2013366.","journal-title":"Pharm Biol"},{"key":"4238_CR76","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/bph.16219","volume":"181","author":"H Miao","year":"2024","unstructured":"Miao H, Wang YN, Yu XY, et al. Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites. Br J Pharmacol 2024;181:162\u2013179.","journal-title":"Br J Pharmacol"},{"key":"4238_CR77","doi-asserted-by":"publisher","first-page":"110325","DOI":"10.1016\/j.biopha.2020.110325","volume":"129","author":"T Zhao","year":"2020","unstructured":"Zhao T, Zhang H, Yin X, et al. Tangshen Formula modulates gut microbiota and reduces gut-derived toxins in diabetic nephropathy rats. Biomed Pharmacother 2020;129:110325.","journal-title":"Biomed Pharmacother"},{"key":"4238_CR78","doi-asserted-by":"publisher","first-page":"122728","DOI":"10.1016\/j.jchromb.2021.122728","volume":"1174","author":"ZM Zhang","year":"2021","unstructured":"Zhang ZM, Yang L, Wan Y, et al. Integrated gut microbiota and fecal metabolomics reveal the renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced CKD rats. J Chromatogr B Analyt Technol Biomed Life Sci 2021;1174:122728.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"4238_CR79","doi-asserted-by":"publisher","first-page":"e00012","DOI":"10.1097\/IMNA-D-23-00012","volume":"10","author":"L Li","year":"2023","unstructured":"Li L, Yang Yn, Cao Y, et al. Perspective on the modern interpretation of the property theory of mild-natured and sweet-flavored traditional Chinese medicine via gut microbiota modulation. Integr Med Nephrol Androl 2023;10:e00012.","journal-title":"Integr Med Nephrol Androl"},{"key":"4238_CR80","doi-asserted-by":"publisher","first-page":"2429693","DOI":"10.1080\/0886022X.2024.2429693","volume":"46","author":"W Liu","year":"2024","unstructured":"Liu W, Zhang Y, Hu D, et al. Oral Astragalus polysaccharide alleviates adenine-induced kidney injury by regulating gut microbiota-short-chain fatty acids-kidney G protein-coupled receptors axis. Ren Fail 2024;46:2429693.","journal-title":"Ren Fail"},{"key":"4238_CR81","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.apsb.2022.12.010","volume":"13","author":"L Pan","year":"2023","unstructured":"Pan L, Yu H, Fu J, et al. Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota. Acta Pharm Sin B 2023;13:1537\u20131553.","journal-title":"Acta Pharm Sin B"},{"key":"4238_CR82","doi-asserted-by":"publisher","first-page":"114830","DOI":"10.1016\/j.celrep.2024.114830","volume":"43","author":"ZL Si","year":"2024","unstructured":"Si ZL, Wang HY, Wang T, et al. Gut bacteroides ovatus ameliorates renal fibrosis by promoting the production of HDCA through upregulation of Clostridium scindens. Cell Rep 2024;43:114830.","journal-title":"Cell Rep"},{"key":"4238_CR83","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1038\/s41467-022-33824-6","volume":"13","author":"W Zhou","year":"2022","unstructured":"Zhou W, Wu WH, Si ZL, et al. The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice. Nat Commun 2022;13:6081.","journal-title":"Nat Commun"},{"key":"4238_CR84","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41392-024-01913-1","volume":"9","author":"H Miao","year":"2024","unstructured":"Miao H, Liu F, Wang YN, et al. Targeting Lactobacillus johnsonii to reverse chronic kidney disease. Signal Transduct Target Ther 2024;9:195.","journal-title":"Signal Transduct Target Ther"},{"key":"4238_CR85","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.2147\/DDDT.S521265","volume":"19","author":"HY Feng","year":"2025","unstructured":"Feng HY, Wang YQ, Yang J, et al. Anthraquinones from Rheum officinale ameliorate renal fibrosis in acute kidney injury and chronic kidney disease. Drug Des Devel Ther 2025;19:5739\u20135760.","journal-title":"Drug Des Devel Ther"},{"key":"4238_CR86","first-page":"1896781","volume":"2022","author":"C Ji","year":"2022","unstructured":"Ji C, Lu F, Wu Y, et al. Rhubarb Enema increasing short-chain fatty acids that improves the intestinal barrier disruption in CKD may be related to the regulation of gut dysbiosis. J Biomed Biotechnol 2022;2022:1896781.","journal-title":"J Biomed Biotechnol"},{"key":"4238_CR87","doi-asserted-by":"publisher","first-page":"e71186","DOI":"10.1002\/fsn3.71186","volume":"13","author":"Z Gao","year":"2025","unstructured":"Gao Z, Tang Y, Huang L, et al. A new strategy for treating renal fibrosis based on a drug-food homogeneous formula of traditional Chinese medicine. Food Sci Nutr 2025;13:e71186.","journal-title":"Food Sci Nutr"},{"key":"4238_CR88","doi-asserted-by":"publisher","first-page":"789521","DOI":"10.3389\/fmed.2021.789521","volume":"8","author":"F Zhang","year":"2021","unstructured":"Zhang F, Liao J, Zhang W, et al. Effects of Baduanjin exercise on physical function and health-related quality of life in peritoneal dialysis patients: a randomized trial. Front Med (Lausanne) 2021;8:789521.","journal-title":"Front Med (Lausanne)"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4238-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-026-4238-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4238-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:28:06Z","timestamp":1785518886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-026-4238-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":88,"alternative-id":["4238"],"URL":"https:\/\/doi.org\/10.1007\/s11655-026-4238-1","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"14 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}